Galliford Try Holdings plc (LSE:GFRD) has signaled that its financial results for 2025 are set to outperform market forecasts, with both revenue and adjusted profit before tax expected to come in slightly above the highest analyst predictions. This robust showing is driven by sustained success across its core divisions and specialist services, notably within water and highways projects.

The company is targeting sustainable margin improvements by 2030, supported by a strong balance sheet free of pension obligations and bank debt. With an order book valued at £4.1 billion, approximately 90% of projected revenue for the coming year is already secured. Galliford Try remains optimistic about ongoing opportunities in the UK’s social infrastructure and economic development sectors.

Financial indicators reflect a solid recovery and appealing valuation, while technical analysis points to positive momentum, though the stock may be approaching overbought territory. Additionally, a recent share buyback program underscores management’s commitment to enhancing shareholder returns and confidence.

About Galliford Try Holdings plc

Galliford Try is a prominent UK-based construction and infrastructure group, publicly traded on the London Stock Exchange. Operating under the Galliford Try and Morrison Construction brands, the company delivers a broad range of building and infrastructure projects, including environment, highways, and social infrastructure, serving clients across public, private, and regulated markets throughout the UK.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.